BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinnari PJ, Hyvönen ML, Mäkilä EM, Kaasalainen MH, Rivinoja A, Salonen JJ, Hirvonen JT, Laakkonen PM, Santos HA. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. Biomaterials 2013;34:9134-41. [PMID: 24008034 DOI: 10.1016/j.biomaterials.2013.08.034] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Figueiredo P, Bauleth-ramos T, Hirvonen J, Sarmento B, Santos HA. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine. Handbook of Nanomaterials for Cancer Theranostics. Elsevier; 2018. pp. 1-31. [DOI: 10.1016/b978-0-12-813339-2.00001-3] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Martín-Palma RJ, Hernández-Montelongo J, Torres-Costa V, Manso-Silván M, Muñoz-Noval Á. Nanostructured porous silicon-mediated drug delivery. Expert Opin Drug Deliv 2014;11:1273-83. [PMID: 24941438 DOI: 10.1517/17425247.2014.919254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
3 Feng X, Gao X, Kang T, Jiang D, Yao J, Jing Y, Song Q, Jiang X, Liang J, Chen J. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG–PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy. Bioconjugate Chem 2015;26:1850-61. [DOI: 10.1021/acs.bioconjchem.5b00379] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
4 Wang C, Mäkilä EM, Kaasalainen MH, Hagström MV, Salonen JJ, Hirvonen JT, Santos HA. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy. Acta Biomaterialia 2015;16:206-14. [DOI: 10.1016/j.actbio.2015.01.021] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 7.9] [Reference Citation Analysis]
5 Li X, Jian M, Sun Y, Zhu Q, Wang Z. The Peptide Functionalized Inorganic Nanoparticles for Cancer-Related Bioanalytical and Biomedical Applications. Molecules 2021;26:3228. [PMID: 34072160 DOI: 10.3390/molecules26113228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang B, Prinsen P, Wang H, Bai Z, Wang H, Luque R, Xuan J. Macroporous materials: microfluidic fabrication, functionalization and applications. Chem Soc Rev 2017;46:855-914. [DOI: 10.1039/c5cs00065c] [Cited by in Crossref: 83] [Cited by in F6Publishing: 17] [Article Influence: 16.6] [Reference Citation Analysis]
7 Colpitis C, Kiani A. Synthesis of Bioactive Three-Dimensional Silicon-Oxide Nanofibrous Structures on the Silicon Substrate for Bionic Devices' Fabrication. Nanomaterials and Nanotechnology 2016;6:8. [DOI: 10.5772/62312] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yang Y, Wang A, Jia Y, Brezesinski G, Dai L, Zhao J, Li J. Peptide p160-Coated Silica Nanoparticles Applied in Photodynamic Therapy. Chem Asian J 2014;9:2126-31. [DOI: 10.1002/asia.201402141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
9 Ayo A, Laakkonen P. Peptide-Based Strategies for Targeted Tumor Treatment and Imaging. Pharmaceutics 2021;13:481. [PMID: 33918106 DOI: 10.3390/pharmaceutics13040481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Le Joncour V, Laakkonen P. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem 2018;26:2797-806. [PMID: 28893601 DOI: 10.1016/j.bmc.2017.08.052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
11 Nissinen T, Näkki S, Laakso H, Kučiauskas D, Kaupinis A, Kettunen MI, Liimatainen T, Hyvönen M, Valius M, Gröhn O, Lehto V. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo. ACS Appl Mater Interfaces 2016;8:32723-31. [DOI: 10.1021/acsami.6b12481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
12 Näkki S, Rytkönen J, Nissinen T, Florea C, Riikonen J, Ek P, Zhang H, Santos HA, Närvänen A, Xu W, Lehto V. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration. Acta Biomaterialia 2015;13:207-15. [DOI: 10.1016/j.actbio.2014.11.019] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
13 Ferreira MP, Ranjan S, Correia AM, Mäkilä EM, Kinnunen SM, Zhang H, Shahbazi MA, Almeida PV, Salonen JJ, Ruskoaho HJ, Airaksinen AJ, Hirvonen JT, Santos HA. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials 2016;94:93-104. [PMID: 27107168 DOI: 10.1016/j.biomaterials.2016.03.046] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
14 Xia B, Wang B, Chen Z, Zhang Q, Shi J. Near-Infrared Light-Triggered Intracellular Delivery of Anticancer Drugs Using Porous Silicon Nanoparticles Conjugated with IR820 Dyes. Adv Mater Interfaces 2016;3:1500715. [DOI: 10.1002/admi.201500715] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
15 Farshbaf M, Valizadeh H, Panahi Y, Fatahi Y, Chen M, Zarebkohan A, Gao H. The impact of protein corona on the biological behavior of targeting nanomedicines. Int J Pharm 2022;614:121458. [PMID: 35017025 DOI: 10.1016/j.ijpharm.2022.121458] [Reference Citation Analysis]
16 Figueiredo P, Balasubramanian V, Shahbazi M, Correia A, Wu D, Palivan CG, Hirvonen JT, Santos HA. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells. International Journal of Pharmaceutics 2016;511:794-803. [DOI: 10.1016/j.ijpharm.2016.07.066] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
17 Zhao L, Zhang Y, Shao J, Liang H, Na H, Zhu J. Folate-conjugated dually responsive micelles for targeted anticancer drug delivery. RSC Adv 2016;6:35658-67. [DOI: 10.1039/c6ra01885h] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
18 Luu QS, Kim J, Jo D, Jeong J, Lee Y. Applications and perspective of silicon particles in hyperpolarized 29 Si magnetic resonance imaging. Applied Spectroscopy Reviews 2020;55:476-90. [DOI: 10.1080/05704928.2019.1676255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Almeida PV, Shahbazi MA, Correia A, Mäkilä E, Kemell M, Salonen J, Hirvonen J, Santos HA. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect. Nanomedicine (Lond) 2017;12:1401-20. [PMID: 28524813 DOI: 10.2217/nnm-2017-0034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
20 Santos HA, Mäkilä E, Airaksinen A, Bimbo L, Hirvonen J. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications. Nanomedicine 2014;9:535-54. [DOI: 10.2217/nnm.13.223] [Cited by in Crossref: 123] [Cited by in F6Publishing: 89] [Article Influence: 15.4] [Reference Citation Analysis]
21 Ayo A, Figueras E, Schachtsiek T, Budak M, Sewald N, Laakkonen P. Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI). Cancers (Basel) 2020;12:E1836. [PMID: 32650473 DOI: 10.3390/cancers12071836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liu D, Herranz-blanco B, Mäkilä E, Arriaga LR, Mirza S, Weitz DA, Sandler N, Salonen J, Hirvonen J, Santos HA. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery. ACS Appl Mater Interfaces 2013;5:12127-34. [DOI: 10.1021/am403999q] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
23 Domb AJ, Sharifzadeh G, Nahum V, Hosseinkhani H. Safety Evaluation of Nanotechnology Products. Pharmaceutics 2021;13:1615. [PMID: 34683908 DOI: 10.3390/pharmaceutics13101615] [Reference Citation Analysis]
24 Tölli MA, Ferreira MP, Kinnunen SM, Rysä J, Mäkilä EM, Szabó Z, Serpi RE, Ohukainen PJ, Välimäki MJ, Correia AM, Salonen JJ, Hirvonen JT, Ruskoaho HJ, Santos HA. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart. Biomaterials 2014;35:8394-405. [PMID: 24985734 DOI: 10.1016/j.biomaterials.2014.05.078] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
25 Herranz-Blanco B, Arriaga LR, Mäkilä E, Correia A, Shrestha N, Mirza S, Weitz DA, Salonen J, Hirvonen J, Santos HA. Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. Lab Chip 2014;14:1083-6. [PMID: 24469311 DOI: 10.1039/c3lc51260f] [Cited by in Crossref: 60] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
26 Jakobsson U, Mäkilä E, Airaksinen AJ, Alanen O, Etilé A, Köster U, Ranjan S, Salonen J, Santos HA, Helariutta K. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid. Contrast Media Mol Imaging 2019;2019:3728563. [PMID: 30992696 DOI: 10.1155/2019/3728563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
27 Hyvönen M, Laakkonen P. Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display. In: Langel Ü, editor. Cell-Penetrating Peptides. New York: Springer; 2015. pp. 205-22. [DOI: 10.1007/978-1-4939-2806-4_14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
28 Sahlgren C, Meinander A, Zhang H, Cheng F, Preis M, Xu C, Salminen TA, Toivola D, Abankwa D, Rosling A, Karaman DŞ, Salo-Ahen OMH, Österbacka R, Eriksson JE, Willför S, Petre I, Peltonen J, Leino R, Johnson M, Rosenholm J, Sandler N. Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems. Adv Healthc Mater 2017;6. [PMID: 28892296 DOI: 10.1002/adhm.201700258] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
29 Almeida PV, Shahbazi MA, Mäkilä E, Kaasalainen M, Salonen J, Hirvonen J, Santos HA. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors. Nanoscale 2014;6:10377-87. [PMID: 25074521 DOI: 10.1039/c4nr02187h] [Cited by in Crossref: 76] [Cited by in F6Publishing: 13] [Article Influence: 10.9] [Reference Citation Analysis]
30 Tzur-balter A, Shtenberg G, Segal E. Porous silicon for cancer therapy: from fundamental research to the clinic. Reviews in Chemical Engineering 2015;31. [DOI: 10.1515/revce-2015-0001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
31 Figueiredo P, Lintinen K, Kiriazis A, Hynninen V, Liu Z, Bauleth-ramos T, Rahikkala A, Correia A, Kohout T, Sarmento B, Yli-kauhaluoma J, Hirvonen J, Ikkala O, Kostiainen MA, Santos HA. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells. Biomaterials 2017;121:97-108. [DOI: 10.1016/j.biomaterials.2016.12.034] [Cited by in Crossref: 167] [Cited by in F6Publishing: 136] [Article Influence: 33.4] [Reference Citation Analysis]
32 Roveri M, Bernasconi M, Leroux J, Luciani P. Peptides for tumor-specific drug targeting: state of the art and beyond. J Mater Chem B 2017;5:4348-64. [DOI: 10.1039/c7tb00318h] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
33 Wang C, Sarparanta MP, Mäkilä EM, Hyvönen ML, Laakkonen PM, Salonen JJ, Hirvonen JT, Airaksinen AJ, Santos HA. Multifunctional porous silicon nanoparticles for cancer theranostics. Biomaterials 2015;48:108-18. [DOI: 10.1016/j.biomaterials.2015.01.008] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 16.3] [Reference Citation Analysis]
34 Roychaudhuri C. A review on porous silicon based electrochemical biosensors: Beyond surface area enhancement factor. Sensors and Actuators B: Chemical 2015;210:310-23. [DOI: 10.1016/j.snb.2014.12.089] [Cited by in Crossref: 51] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
35 Mu C, Shen H. Silicon Nanoparticles and Microparticles. In: Lu Z, Sakuma S, editors. Nanomaterials in Pharmacology. New York: Springer; 2016. pp. 153-83. [DOI: 10.1007/978-1-4939-3121-7_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Tamarov K, Näkki S, Xu W, Lehto VP. Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles. J Mater Chem B 2018;6:3632-49. [PMID: 32254826 DOI: 10.1039/c8tb00462e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
37 Balasubramanian V, Domanskyi A, Renko JM, Sarparanta M, Wang CF, Correia A, Mäkilä E, Alanen OS, Salonen J, Airaksinen AJ, Tuominen R, Hirvonen J, Airavaara M, Santos HA. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke. Biomaterials 2020;227:119556. [PMID: 31670035 DOI: 10.1016/j.biomaterials.2019.119556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
38 Santos HA. Chemotherapy with Porous Silicon. In: Canham L, editor. Handbook of Porous Silicon. Cham: Springer International Publishing; 2016. pp. 1-15. [DOI: 10.1007/978-3-319-04508-5_128-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Zhang DX, Esser L, Vasani RB, Thissen H, Voelcker NH. Porous silicon nanomaterials: recent advances in surface engineering for controlled drug-delivery applications. Nanomedicine (Lond) 2019;14:3213-30. [PMID: 31855121 DOI: 10.2217/nnm-2019-0167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Stojanovic V, Cunin F, Durand JO, Garcia M, Gary-bobo M. Potential of porous silicon nanoparticles as an emerging platform for cancer theranostics. J Mater Chem B 2016;4:7050-9. [DOI: 10.1039/c6tb01829g] [Cited by in Crossref: 23] [Article Influence: 3.8] [Reference Citation Analysis]
41 Liu D, Zhang H, Mäkilä E, Fan J, Herranz-blanco B, Wang C, Rosa R, Ribeiro AJ, Salonen J, Hirvonen J, Santos HA. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy. Biomaterials 2015;39:249-59. [DOI: 10.1016/j.biomaterials.2014.10.079] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 14.1] [Reference Citation Analysis]
42 Shahbazi M, Fernández TD, Mäkilä EM, Le Guével X, Mayorga C, Kaasalainen MH, Salonen JJ, Hirvonen JT, Santos HA. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms. Biomaterials 2014;35:9224-35. [DOI: 10.1016/j.biomaterials.2014.07.050] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
43 Liu D, Zhang H, Herranz-blanco B, Mäkilä E, Lehto V, Salonen J, Hirvonen J, Santos HA. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery. Small 2014;10:2029-38. [DOI: 10.1002/smll.201303740] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 11.0] [Reference Citation Analysis]
44 Mcinnes SJP, Santos A, Kumeria T. Porous Silicon Particles for Cancer Therapy and Bioimaging. In: Gonçalves G, Tobias G, editors. Nanooncology. Cham: Springer International Publishing; 2018. pp. 305-40. [DOI: 10.1007/978-3-319-89878-0_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Shahbazi M, Almeida PV, Mäkilä E, Correia A, Ferreira MPA, Kaasalainen M, Salonen J, Hirvonen J, Santos HA. Poly(methyl vinyl ether- alt -maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization. Macromol Rapid Commun 2014;35:624-9. [DOI: 10.1002/marc.201300868] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
46 Shahbazi M, Almeida PV, Mäkilä EM, Kaasalainen MH, Salonen JJ, Hirvonen JT, Santos HA. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering. Biomaterials 2014;35:7488-500. [DOI: 10.1016/j.biomaterials.2014.05.020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
47 Croissant JG, Fatieiev Y, Khashab NM. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles. Adv Mater 2017;29. [PMID: 28084658 DOI: 10.1002/adma.201604634] [Cited by in Crossref: 311] [Cited by in F6Publishing: 283] [Article Influence: 62.2] [Reference Citation Analysis]
48 Seyyednia E, Oroojalian F, Baradaran B, Mojarrad JS, Mokhtarzadeh A, Valizadeh H. Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging. J Control Release 2021;338:367-93. [PMID: 34461174 DOI: 10.1016/j.jconrel.2021.08.044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kovalainen M, Mönkäre J, Riikonen J, Pesonen U, Vlasova M, Salonen J, Lehto VP, Järvinen K, Herzig KH. Novel delivery systems for improving the clinical use of peptides. Pharmacol Rev 2015;67:541-61. [PMID: 26023145 DOI: 10.1124/pr.113.008367] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
50 Kulyavtsev PA, Spencer RP. Drug delivery via porous silicon: a focused patent review. Pharmaceutical Patent Analyst 2017;6:77-85. [DOI: 10.4155/ppa-2016-0042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Li W, Liu Z, Fontana F, Ding Y, Liu D, Hirvonen JT, Santos HA. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy. Adv Mater 2018;30:e1703740. [PMID: 29534311 DOI: 10.1002/adma.201703740] [Cited by in Crossref: 76] [Cited by in F6Publishing: 57] [Article Influence: 19.0] [Reference Citation Analysis]
52 Owen J, Grove P, Rademeyer P, Stride E. The influence of blood on targeted microbubbles. J R Soc Interface 2014;11:20140622. [PMID: 25253034 DOI: 10.1098/rsif.2014.0622] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
53 Bertucci A, Kim KH, Kang J, Zuidema JM, Lee SH, Kwon EJ, Kim D, Howell SB, Ricci F, Ruoslahti E, Jang HJ, Sailor MJ. Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy. ACS Appl Mater Interfaces 2019;11:23926-37. [PMID: 31251556 DOI: 10.1021/acsami.9b07980] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
54 Xia B, Zhang W, Shi J, Xiao S. A novel strategy to fabricate doxorubicin/bovine serum albumin/porous silicon nanocomposites with pH-triggered drug delivery for cancer therapy in vitro. J Mater Chem B 2014;2:5280. [DOI: 10.1039/c4tb00307a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
55 Zhou L, Zhou J, Feng Z, Wang F, Xie S, Bu S. Immunoassay for tumor markers in human serum based on Si nanoparticles and SiC@Ag SERS-active substrate. Analyst 2016;141:2534-41. [DOI: 10.1039/c6an00003g] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
56 Herranz-blanco B, Liu D, Mäkilä E, Shahbazi M, Ginestar E, Zhang H, Aseyev V, Balasubramanian V, Salonen J, Hirvonen J, Santos HA. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications. Adv Funct Mater 2015;25:1488-97. [DOI: 10.1002/adfm.201404122] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
57 Liu J, Chang Q, Bao M, Yuan B, Yang K, Ma Y. Silicon quantum dots delivered phthalocyanine for fluorescence guided photodynamic therapy of tumor. Chinese Phys B 2017;26:098102. [DOI: 10.1088/1674-1056/26/9/098102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]